# A Study of Influenza Virus Vaccines in Children and Adults

> **NCT00988143** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 600 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** 2009-2010 Trivalent Influenza Virus Vaccine
- **BIOLOGICAL:** 2008-2009 Trivalent Influenza Virus Vaccine
- **BIOLOGICAL:** Quadrivalent Influenza Virus Vaccine

## Key facts

- **NCT ID:** NCT00988143
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-12
- **Final completion:** 2010-03
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2013-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00988143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00988143, "A Study of Influenza Virus Vaccines in Children and Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00988143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*